The risk of long COVID was two to three times higher after the initial infection (14.8%) than after first (5.8%) or second (5.3%) reinfections.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
Prepandemic sleep patterns, sleep duration, insomnia, and daytime dysfunction were tied to risk of long COVID after adjusting for age, race, and ethnicity.
About 25% of 750 survey respondents met the criteria for alcohol misuse, with 5% classified as binge drinkers.
First Nations people, who are at high risk for poor COVID-19 outcomes, had robust immune responses to the Pfizer/BioNTech vaccine.
Hospitalizations for COVID-19 are down 11% compared to a week ago, and deaths from the virus are down 13.3%.
From 2020 to early 2022 in England, the COVID-19 infection-fatality ratio decreased from 0.67% to 0.10%.
Delayed diagnoses of lung, breast, and colorectal cancers will likely be on the rise because of missed cancer screenings during the pandemic.
Protection against ICU admission and death was 69% 1 week to 2 months after a bivalent dose and 50% at 4 to 6 months.
Leading the list of symptoms are post-exertion malaise, fatigue, brain fog, dizziness, GI symptoms, heart palpitations, and changes in sexual desire.
In another COVID development, the FDA today announced full approval for the use of Paxlovid in adults at risk for more severe disease.
Data suggest an increased risk of new-onset mental illness only in SARS-CoV-2–positive patients aged 70 and older.
